HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemoglobin Optimization for Coronary Bypass: A 10-Year Canadian Multicenter Experience.

AbstractBACKGROUND:
We report our 10-year experience of a multicenter hemoglobin optimization program with the aim to reduce red blood cell transfusion in patients undergoing coronary artery bypass grafting (CABG).
METHODS:
From 2006 to 2016, patients undergoing CABG at 10 centers in Ontario were referred to the Ontario Transfusion Coordinators (ONTraC) program. Of these, we present data on the first 60 consecutive patients per center, per year (n = 6,145).
RESULTS:
Overall, 45.7% patients were assessed <14 days preoperatively, 16.4% were assessed ≥14 days preoperatively, and 37.9% were not assessed by ONTraC preoperatively. Transfusion rates fell from 40.1% in 2006 to 26.2% in 2016 (p < 0.01). Patients undergoing assessment were more likely to be older (p < 0.01), female (p < 0.01), and anemic (p < 0.01) versus nonassessed patients. Those patients assessed were more likely to be treated with iron (p < 0.01) and erythropoietin (p < 0.01) preoperatively versus nonassessed patients. Transfusion rates were 26%, 28%, and 28% for patients undergoing assessment ≥14 days prior to operation, <14 days prior to operation, or not at all. After baseline covariate adjustment, patients assessed ≥14 days preoperatively had shorter length of stay (effect -0.83, 95% confidence interval [CI] -1.41 to -0.25; p < 0.01) and a trend towards lower risk of red blood cell transfusion (odds ratio [OR] 0.83, 95% CI 0.68 to 1.00; p = 0.06). Blood transfusion was independently associated with an increased risk of death (OR 1.49, 95% CI 1.37 to 1.60; p < 0.01), infection (OR 1.24, 95% CI 1.18 to 1.30; p < 0.01), and longer hospital length of stay (effect 1.49, 95% CI 1.35 to 1.62; p < 0.01).
CONCLUSIONS:
The results of this study suggest that preoperative hemoglobin optimization may be effective in reducing red blood cell transfusion after CABG, particularly for patients assessed ≥14 days preoperatively.
AuthorsBobby Yanagawa, Rodolfo V Rocha, Amine Mazine, Subodh Verma, C David Mazer, Lee Vernich, David Latter, John Freedman
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 107 Issue 3 Pg. 711-717 (03 2019) ISSN: 1552-6259 [Electronic] Netherlands
PMID30529670 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Hemoglobins
Topics
  • Aged
  • Coronary Artery Bypass (methods)
  • Erythrocyte Transfusion (methods)
  • Female
  • Follow-Up Studies
  • Forecasting
  • Hemoglobins (metabolism)
  • Humans
  • Incidence
  • Length of Stay (trends)
  • Male
  • Middle Aged
  • Ontario (epidemiology)
  • Postoperative Complications (epidemiology, prevention & control)
  • Preoperative Care (methods)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: